0000950170-24-063281.txt : 20240522
0000950170-24-063281.hdr.sgml : 20240522
20240522072210
ACCESSION NUMBER: 0000950170-24-063281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weber Darin J.
CENTRAL INDEX KEY: 0001936228
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40560
FILM NUMBER: 24971641
MAIL ADDRESS:
STREET 1: C/O PROKIDNEY CORP.
STREET 2: 3929 WESTPOINT BLVD., SUITE G
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROKIDNEY CORP.
CENTRAL INDEX KEY: 0001850270
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981586514
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 FRONTIS PLAZA BLVD.
STREET 2: SUITE 250
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
BUSINESS PHONE: 336-999-7028
MAIL ADDRESS:
STREET 1: 2000 FRONTIS PLAZA BLVD.
STREET 2: SUITE 250
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
FORMER COMPANY:
FORMER CONFORMED NAME: Social Capital Suvretta Holdings Corp. III
DATE OF NAME CHANGE: 20210310
4
1
ownership.xml
4
X0508
4
2024-05-20
0001850270
PROKIDNEY CORP.
PROK
0001936228
Weber Darin J.
C/O PROKIDNEY CORP
2000 FRONTIS PLAZA BLVD, SUITE 250
WINSTON-SALEM
NC
27103
false
true
false
false
Chief Regulatory Officer
true
Class A Ordinary Shares
2024-05-20
4
S
false
17238
4.0832
D
137956
D
The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.74 to $4.44, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Todd Girolamo, attorney in fact
2024-05-22